SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-020609
Filing Date
2023-04-26
Accepted
2023-04-26 16:37:56
Documents
6
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A edge20008374x1_def14a.htm DEF 14A 1018667
2 edge20008374x1-pc_1.jpg GRAPHIC 663970
3 edge20008374x1-pc_2.jpg GRAPHIC 466196
4 edge20008374x1_barchart01.jpg GRAPHIC 102973
5 edge20008374x1_barchart02.jpg GRAPHIC 91107
6 logo_eiger.jpg GRAPHIC 31688
  Complete submission text file 0001140361-23-020609.txt   2885924
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36183 | Film No.: 23850358
SIC: 2836 Biological Products, (No Diagnostic Substances)